ARCHIVES

Major Decisions On How NCI Will Spend Extra Money Won’t Be Made for Three-Four Months

This article is from The Cancer Letter archive.

Vol. 09 No. 42 | November 4, 1983

Download PDF Visit The Full Archive

Related Articles

NCA Approves Draft of New Outstanding Investigator Grants

February 10, 1984

NCI’s SBIR Paylines Nears Regular Grants

September 20, 1985

Conferees Agree On Extension Of Biomedical Research Authorities For Two Years; Kennedy-Waxman Bills Are Dead

November 28, 1980

Novartis Submits Gleevec Data To FDA Seeking Approval For Use In GI Tumors.

October 26, 2001

Private Sector Still Valuable To National Cancer Program, ACS Research Chief Says

April 26, 1974

FDA Advisors Ok Marketing Of Taxotere As Treatment For Advanced Breast Cancer

October 20, 1995